Recombinant Chromobacterium violaceum Anthranilate phosphoribosyltransferase (trpD)

Shipped with Ice Packs
In Stock

Description

Function and Role in Tryptophan Biosynthesis

In the tryptophan biosynthesis pathway, anthranilate phosphoribosyltransferase (TrpD) plays a pivotal role by facilitating the conversion of anthranilate into phosphoribosyl anthranilate. This step is essential for the subsequent synthesis of tryptophan, an aromatic amino acid vital for protein synthesis and cellular growth. In Chromobacterium violaceum, tryptophan is also used in the synthesis of violacein, a secondary metabolite with pharmacological interest .

Comparison with Other Organisms

In Saccharomyces cerevisiae, the TrpD enzyme encoded by the trp4 gene exhibits higher affinity for PRPP and greater enzymatic activity compared to its E. coli counterpart . This highlights the potential for improving tryptophan production by using more efficient TrpD variants in biotechnological applications.

Data Tables

Given the lack of specific data on recombinant Chromobacterium violaceum TrpD, we can refer to general kinetic parameters of TrpD enzymes from other sources:

Enzyme SourceApparent KmK_m for Anthranilate (μ\muM)Apparent KmK_m for PRPP (μ\muM)Specific Activity (μ\mumol·min1^{-1}·mg1^{-1})
Thermococcus kodakarensis2.22501580
E. coli---
Saccharomyces cerevisiae-Higher affinity than E. coli-

Note: The table provides a general overview of TrpD enzyme properties. Specific data for Chromobacterium violaceum TrpD are not available.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
trpD; CV_2173; Anthranilate phosphoribosyltransferase; EC 2.4.2.18
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-342
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Chromobacterium violaceum (strain ATCC 12472 / DSM 30191 / JCM 1249 / NBRC 12614 / NCIMB 9131 / NCTC 9757)
Target Names
trpD
Target Protein Sequence
MITPQAALNR LIDGNELFYD EMLALMRQIM RGELSPAQTA AILIGLRVKV ESVSEIAAAA TVMREFATHV PVSDRRHLVD TCGTGGDKSH TFNISTTSAF VAAAAGARVA KHGGRSVSSS SGSADVLELL GVNLQLTPEQ VGQCLDEIGL GFMFAPNHHS AMKHVAPIRK ELGARTIFNI LGPLTNPAAA DHQLMGVFHP DLVGIQSRVL KMLGSRHVMI VHGCDGLDEL TLSGPSMVAE LKNGEILEYE LEPGEFGFPL CELKDLRADT AAQSRDRLLA VLDGQPGPAR DIVLLNAGAA IYTADIAPSL ADGVTMAREA LDSGKAKQKL QQLIALSRKL GG
Uniprot No.

Target Background

Function
Catalyzes the transfer of the phosphoribosyl group from 5-phosphoribosyl-1-pyrophosphate (PRPP) to anthranilate, yielding N-(5'-phosphoribosyl)-anthranilate (PRA).
Database Links

KEGG: cvi:CV_2173

STRING: 243365.CV_2173

Protein Families
Anthranilate phosphoribosyltransferase family

Q&A

What is the role of anthranilate phosphoribosyltransferase (TrpD) in tryptophan biosynthesis?

Anthranilate phosphoribosyltransferase (TrpD) catalyzes the second step in the tryptophan biosynthetic pathway, introducing a phosphoribosyl moiety from 5-phosphoribosyl pyrophosphate (PRPP) to the amino group of anthranilate, yielding phosphoribosyl anthranilate (PRA). This reaction represents a critical junction in the pathway, linking the initial anthranilate synthesis step with subsequent reactions leading to tryptophan formation. In C. violaceum, TrpD plays a particularly significant role as a control point in tryptophan biosynthesis and influences the production of violacein, a distinctive purple pigment derived from tryptophan .

How is the trpD gene organized in Chromobacterium violaceum compared to other bacteria?

Unlike E. coli where trp genes are organized in an operon, C. violaceum's trp genes (including trpD) are not organized into an operon but are mostly scattered throughout the genome as single copies. Specifically, trpD in C. violaceum is designated as ORF CV2173 in the genome. The trp genes in C. violaceum appear to form clusters with genes not related to tryptophan biosynthesis, representing a distinct genomic organization compared to the well-characterized trp operon of E. coli . This dispersed arrangement may reflect evolutionary adaptations related to the dual metabolic role of tryptophan in C. violaceum—for protein synthesis and as a precursor for violacein pigment production .

What is the relationship between TrpD activity and violacein production in C. violaceum?

Violacein biosynthesis in C. violaceum requires tryptophan as its sole precursor, with two tryptophan molecules needed to produce one violacein molecule. Since TrpD catalyzes a critical step in tryptophan biosynthesis, its activity directly impacts the availability of tryptophan for violacein production. The regulation of violacein biosynthesis involves quorum sensing through N-hexanoyl-homoserine-lactone (HHL), which is mediated by the cviI and cviR genes. When C. violaceum growth reaches near stationary phase, accumulation of HHL triggers violacein production pathways. Therefore, optimal TrpD activity is essential for maintaining sufficient tryptophan pools that can be directed toward violacein synthesis .

What are the recommended methods for cloning and expressing recombinant C. violaceum TrpD?

For successful cloning and expression of recombinant C. violaceum TrpD:

  • Gene Identification and Amplification:

    • Identify the trpD gene (ORF CV2173) in the C. violaceum genome

    • Design primers with appropriate restriction sites for directional cloning

    • Use high-fidelity DNA polymerase for PCR amplification

  • Expression System Selection:

    • E. coli BL21(DE3) is commonly used for expression of trpD

    • Consider using pET-based vectors with T7 promoter systems

    • Include affinity tags (6×His) for purification purposes

  • Expression Optimization:

    • Test multiple induction conditions (IPTG concentration, temperature, duration)

    • Consider codon optimization if expression levels are low

    • Monitor protein solubility, as overexpression may lead to inclusion bodies

  • Functional Verification:

    • Perform enzymatic assays to confirm TrpD activity by measuring conversion of anthranilate to PRA

    • Verify protein integrity through SDS-PAGE and Western blotting

When working with C. violaceum TrpD, researchers should be aware that unlike E. coli TrpD, it may possess unique properties related to its native role in violacein production pathways .

How can TrpD activity be measured in laboratory conditions?

Measuring TrpD activity requires quantification of either substrate consumption or product formation:

  • Direct Activity Assay:

    • Monitor the conversion of anthranilate to phosphoribosyl anthranilate (PRA)

    • Use spectrofluorometric methods to track decreasing anthranilate fluorescence

    • Standard reaction mixture: anthranilate, PRPP, MgCl₂, in appropriate buffer

  • Coupled Enzyme Assays:

    • Couple TrpD reaction with subsequent pathway enzymes

    • Monitor formation of indole-3-glycerol phosphate using appropriate detection methods

  • Radiochemical Assays:

    • Use ¹⁴C-labeled anthranilate as substrate

    • Measure incorporation of radioactivity into PRA

    • Separate products using chromatographic methods

  • HPLC-Based Methods:

    • Develop HPLC protocols to separate and quantify anthranilate and PRA

    • Use reverse-phase chromatography with appropriate mobile phases

  • Control Experiments:

    • Include negative controls (heat-inactivated enzyme)

    • Use known TrpD inhibitors as positive controls for inhibition studies

    • Perform standard curve calibrations for accurate quantification

When measuring C. violaceum TrpD activity, consider potential feedback inhibition by tryptophan which may affect kinetic measurements and require additional controls .

What purification strategies yield the highest activity for recombinant C. violaceum TrpD?

Optimal purification strategies for maintaining high activity of recombinant C. violaceum TrpD include:

  • Initial Purification Steps:

    • Cell lysis using gentle methods (sonication in short pulses or enzymatic lysis)

    • Clarification by centrifugation at 15,000-20,000 × g

    • Addition of protease inhibitors throughout purification process

  • Chromatography Sequence:

    • For His-tagged TrpD: Immobilized metal affinity chromatography (IMAC)

    • Ion exchange chromatography (IEX) as secondary step

    • Size exclusion chromatography for final polishing and buffer exchange

  • Buffer Optimization:

    • Maintain pH between 7.0-8.0 (typically 50 mM Tris-HCl or phosphate buffer)

    • Include stabilizing agents (5-10% glycerol)

    • Add reducing agents (1-2 mM DTT or β-mercaptoethanol) to prevent oxidation

    • Include low concentrations of MgCl₂ (2-5 mM) as a cofactor

  • Activity Preservation Methods:

    • Store enzyme in small aliquots at -80°C to avoid freeze-thaw cycles

    • Consider addition of substrate analogues or stabilizing ligands

    • Optimize protein concentration (typically 1-5 mg/mL for storage)

  • Quality Control:

    • Assess purity by SDS-PAGE (>95% recommended)

    • Verify activity after each purification step

    • Perform thermal stability assays to ensure proper folding

The purification protocol may need optimization based on specific construct design and expression system, with careful attention to maintaining the native conformation required for catalytic activity .

How can C. violaceum TrpD be engineered to increase tryptophan production?

Engineering C. violaceum TrpD for enhanced tryptophan production can be approached through several strategies:

  • Relieving Feedback Inhibition:

    • Introduce point mutations (similar to S149F/A162E used in C. glutamicum TrpD) to alleviate feedback inhibition by L-tryptophan

    • These modifications can significantly increase L-tryptophan production, as demonstrated in C. glutamicum where such mutations increased production from 0.15 g/L to 2.70 g/L

  • Improving Catalytic Efficiency:

    • Conduct structure-guided mutagenesis targeting active site residues

    • Focus on residues involved in substrate binding and catalysis

    • Introduce mutations that enhance affinity for PRPP, which is often rate-limiting

  • Enzyme Stabilization:

    • Identify and modify residues that affect thermal stability

    • Engineer disulfide bridges or salt bridges to enhance structural integrity

    • Consider computational approaches to identify stabilizing mutations

  • Heterologous Expression of Superior Variants:

    • Replace native trpD with more efficient variants, such as trp4 from Saccharomyces cerevisiae

    • S. cerevisiae TrpD displays higher affinity for PRPP and greater enzymatic activity compared to bacterial variants

    • This approach resulted in significant tryptophan production increases in engineered C. glutamicum strains (from 5.60 g/L to 6.13 g/L)

  • Balancing Pathway Flux:

    • Co-express modified TrpD with other rate-limiting enzymes in the pathway

    • Coordinate expression levels to maintain balanced metabolic flux

    • Consider multi-enzyme complexes or scaffolds to enhance pathway efficiency

These engineering approaches should be implemented with consideration of the entire tryptophan biosynthetic pathway to avoid creating new bottlenecks .

What is the comparative effectiveness of C. violaceum TrpD versus TrpD variants from other organisms in metabolic engineering applications?

The comparative effectiveness of TrpD variants from different organisms reveals significant differences that impact metabolic engineering applications:

Organism SourceKey CharacteristicsRelative ActivityPRPP AffinityFeedback InhibitionApplications
C. violaceumFunctions in violacein production pathwayModerateModeratePresentViolacein production
E. coliPart of trpD bifunctional enzymeModerateModerateMinimalGeneral tryptophan production
S. cerevisiae (trp4)Monofunctional enzymeHighHighMinimalEnhanced tryptophan production
C. glutamicum nativeKey control point in tryptophan biosynthesisModerateModerateStrongLimited tryptophan production
C. glutamicum (S149F/A162E)Feedback-resistant mutantHighModerateMinimalHigh tryptophan production

Research has demonstrated that replacing native C. glutamicum TrpD with S. cerevisiae trp4 in engineered strains resulted in further increased L-tryptophan production (from 5.60 g/L to 6.13 g/L), confirming the superior enzymatic properties of the yeast variant. Unlike bacterial TrpD variants, S. cerevisiae trp4 displays higher affinity for PRPP and greater enzymatic activity, making it particularly valuable for metabolic engineering applications focused on maximizing tryptophan yields .

The effectiveness of each variant must be evaluated in the context of the specific metabolic engineering goal, considering factors such as expression compatibility, protein stability, and pathway integration in the host organism .

How does modulating TrpD expression affect the balance between violacein production and tryptophan availability in C. violaceum?

Modulating TrpD expression creates a complex metabolic balance between violacein production and tryptophan availability in C. violaceum:

The optimal strategy involves fine-tuning TrpD expression in coordination with both growth requirements and the violacein biosynthetic pathway to achieve the desired balance between these competing metabolic fates of tryptophan .

How does C. violaceum TrpD differ structurally and functionally from E. coli and S. cerevisiae homologs?

Structural and functional differences between TrpD homologs from C. violaceum, E. coli, and S. cerevisiae reflect evolutionary adaptations to specific metabolic contexts:

  • Domain Organization:

    • C. violaceum TrpD: Monofunctional enzyme (EC 2.4.2.18)

    • E. coli TrpD: Bifunctional enzyme with N-terminal glutamine amidotransferase (TrpG) and C-terminal anthranilate phosphoribosyltransferase domains

    • S. cerevisiae Trp4: Monofunctional enzyme with higher structural stability

  • Substrate Affinity and Catalytic Efficiency:

    • S. cerevisiae Trp4: Displays higher affinity for PRPP and greater enzymatic activity

    • C. violaceum TrpD: Moderate affinity for substrates, adapted to balance tryptophan synthesis with violacein production

    • E. coli TrpD: Moderate catalytic properties integrated with its bifunctional architecture

  • Regulation Mechanisms:

    • C. violaceum TrpD: Subject to feedback inhibition by L-tryptophan, similar to C. glutamicum TrpD

    • E. coli TrpD: Less susceptible to feedback inhibition by L-tryptophan; regulation occurs primarily at anthranilate synthase step

    • S. cerevisiae Trp4: Regulated primarily at the transcriptional level rather than through direct feedback inhibition

  • Evolutionary Context:

    • C. violaceum: Adapted for dual-purpose tryptophan utilization (protein synthesis and violacein production)

    • E. coli: Optimized for efficient tryptophan synthesis within the trp operon context

    • S. cerevisiae: Evolved for robust activity in eukaryotic cellular environment

  • Structural Features:

    • All contain a core catalytic domain for phosphoribosyl transfer

    • Differences in substrate binding pockets affect interaction with anthranilate and PRPP

    • Variation in regulatory domains correlates with different sensitivity to feedback inhibition

These differences explain why S. cerevisiae Trp4 has proven superior in some metabolic engineering applications, as demonstrated by increased tryptophan production when substituted for bacterial variants in engineered strains .

What lessons from C. glutamicum TrpD engineering can be applied to C. violaceum TrpD?

Key lessons from C. glutamicum TrpD engineering that can be applied to C. violaceum TrpD include:

  • Targeting Feedback Inhibition:

    • The S149F/A162E mutations in C. glutamicum TrpD significantly increased L-tryptophan production by alleviating feedback inhibition

    • Similar mutations could be introduced at corresponding positions in C. violaceum TrpD to reduce its sensitivity to tryptophan inhibition

    • This approach increased production from 0.15 g/L to 2.70 g/L in C. glutamicum, establishing TrpD as a key control point

  • Heterologous Enzyme Substitution:

    • Replacing C. glutamicum TrpD with S. cerevisiae Trp4 further increased tryptophan production to 6.13 g/L

    • A similar substitution strategy could be applied to C. violaceum, potentially enhancing both tryptophan and violacein production

    • The superior catalytic properties of S. cerevisiae Trp4 (higher PRPP affinity and enzymatic activity) make it an attractive candidate

  • Integration with Pathway Optimization:

    • In C. glutamicum, TrpD optimization was most effective when combined with enhancements to other pathway components

    • For C. violaceum, coordinate optimization of TrpD with other enzymes in both tryptophan and violacein pathways would likely yield best results

    • Consider the entire metabolic context, including precursor supply (e.g., E4P and PEP for aromatic amino acid synthesis)

  • Enzyme-Constrained Metabolic Modeling:

    • Metabolic modeling revealed TrpD as a high-demand enzyme for L-tryptophan biosynthesis in C. glutamicum

    • Similar modeling approaches could identify the relative importance of TrpD in C. violaceum's unique metabolic network

    • This would help prioritize engineering efforts based on quantitative predictions of metabolic flux distribution

  • Balancing Growth and Production:

    • Engineering strategies for C. glutamicum balanced tryptophan production with cell growth requirements

    • In C. violaceum, the additional consideration of violacein production requires even more careful metabolic balancing

    • Techniques such as tunable promoters or inducible expression systems could help maintain this balance

These lessons provide a valuable framework for rational engineering of C. violaceum TrpD, though adaptations would be needed to account for its distinct metabolic context and the dual role of tryptophan in this organism .

How might the dual metabolic role of tryptophan in C. violaceum (for protein synthesis and violacein production) have influenced the evolutionary trajectory of its TrpD compared to organisms that use tryptophan solely for protein synthesis?

The dual metabolic demand for tryptophan in C. violaceum has likely exerted unique evolutionary pressures on TrpD that differ from organisms using tryptophan solely for protein synthesis:

  • Adaptive Regulation Mechanisms:

    • C. violaceum has evolved a balance between constitutive tryptophan synthesis for protein production and conditional upregulation for violacein production

    • TrpD may have acquired specific regulatory features that allow rapid modulation of activity in response to changing cellular needs

    • The feedback inhibition properties of C. violaceum TrpD likely reflect a compromise that allows flexible allocation of tryptophan between competing metabolic fates

  • Genomic Organization Adaptations:

    • Unlike the operon structure in E. coli, C. violaceum trp genes are scattered throughout the genome

    • This dispersed arrangement may permit differential regulation of individual trp genes

    • TrpD's genomic context, possibly clustered with genes unrelated to tryptophan biosynthesis, suggests evolution toward integration with broader metabolic networks beyond protein synthesis

  • Catalytic Properties Shaped by Metabolic Demands:

    • TrpD in C. violaceum may have evolved kinetic properties that optimize tryptophan production under conditions favoring violacein synthesis

    • The enzyme might show activity patterns coordinated with quorum sensing mechanisms that trigger violacein production

    • Substrate affinity and inhibition characteristics would reflect the need to rapidly increase tryptophan flux when violacein production is initiated

  • Coevolution with Violacein Pathway:

    • TrpD likely coevolved with the vio gene cluster responsible for violacein biosynthesis

    • Selection pressures would favor TrpD variants that efficiently channel tryptophan to violacein during stationary phase

    • This may have resulted in unique structural or regulatory features not present in organisms that use tryptophan only for protein synthesis

  • Metabolic Efficiency Adaptations:

    • C. violaceum shows an incomplete hexose monophosphate pathway, lacking 6-phosphogluconate dehydrogenase

    • This metabolic adaptation may increase erythrose-4-phosphate (E4P) availability for aromatic amino acid synthesis

    • TrpD may have evolved to function optimally within this distinctive metabolic background that potentially channels more glucose toward aromatic amino acids than other organisms

These evolutionary adaptations represent a fascinating example of enzyme evolution in response to specialized metabolic demands, making C. violaceum TrpD an interesting subject for comparative evolutionary biochemistry studies .

What are the molecular mechanisms behind TrpD feedback inhibition in C. violaceum, and how do they compare with known inhibition mechanisms in other organisms?

The molecular mechanisms of TrpD feedback inhibition in C. violaceum involve specific structural and regulatory features that may differ significantly from other organisms:

  • Structural Basis of Inhibition:

    • C. violaceum TrpD likely possesses an allosteric tryptophan-binding site distinct from the active site

    • Tryptophan binding induces conformational changes that reduce catalytic efficiency

    • The inhibition mechanism appears similar to that in C. glutamicum, where specific residues (corresponding to positions S149 and A162) are critical for tryptophan sensitivity

    • These positions likely form part of the allosteric binding pocket or the transmission pathway for conformational changes

  • Comparative Inhibition Patterns:

    • C. violaceum and C. glutamicum: TrpD is significantly inhibited by tryptophan

    • E. coli: Anthranilate synthase (TrpE) rather than TrpD is the primary target for feedback inhibition

    • S. cerevisiae: Regulation occurs predominantly at the transcriptional level with less direct enzyme inhibition

    • These differences reflect evolutionary adaptations to specific metabolic contexts and regulatory needs

  • Molecular Dynamics During Inhibition:

    • Tryptophan binding likely induces long-range conformational changes affecting:

      • PRPP binding pocket accessibility

      • Catalytic residue positioning

      • Enzyme flexibility and domain movements

    • These changes would reduce catalytic efficiency without completely inactivating the enzyme, allowing fine-tuned regulation

  • Regulatory Integration:

    • TrpD inhibition in C. violaceum may be coordinated with quorum sensing systems that regulate violacein production

    • The inhibition mechanism potentially shows different sensitivity during various growth phases

    • This would allow differential regulation of tryptophan flux toward protein synthesis versus violacein production

  • Evolutionary Significance:

    • The presence of TrpD feedback inhibition in C. violaceum, despite its need for high tryptophan production for violacein, suggests a delicate evolutionary balance

    • This mechanism likely prevents overcommitment of metabolic resources to tryptophan synthesis when not needed for either protein synthesis or violacein production

    • The evolution of this control point differs from E. coli, where regulation focuses on the first pathway step (anthranilate synthase)

Understanding these mechanisms at the molecular level would provide valuable insights for rational engineering of TrpD to enhance either tryptophan or violacein production in biotechnological applications .

What novel approaches could be developed to simultaneously study the real-time dynamics of tryptophan flux between protein synthesis and violacein production pathways in C. violaceum?

Innovative approaches to monitor real-time tryptophan flux between competing metabolic fates in C. violaceum could include:

  • Isotope-Based Flux Analysis with Temporal Resolution:

    • Apply dynamic ¹³C metabolic flux analysis using isotope-labeled precursors

    • Pulse-chase experiments with ¹³C-labeled chorismate or anthranilate

    • Time-course sampling with LC-MS/MS analysis to track labeled tryptophan incorporation into proteins versus violacein

    • Mathematical modeling to quantify flux distributions at different growth phases

  • Genetically Encoded Biosensors:

    • Develop FRET-based tryptophan biosensors using tryptophan-binding domains

    • Create transcriptional biosensors that respond to changes in intracellular tryptophan concentration

    • Engineer reporter systems linked to promoters from protein synthesis and violacein pathways

    • Implement these biosensors in microfluidic platforms for single-cell analysis

  • Optogenetic Control Combined with Real-Time Monitoring:

    • Engineer light-responsive TrpD variants or expression systems

    • Control tryptophan production with spatial and temporal precision

    • Simultaneously monitor violacein production using spectroscopic methods

    • Correlate controlled TrpD activity with metabolic outcomes in real-time

  • Multi-omics Integration with Time-Series Analysis:

    • Perform parallel transcriptomics, proteomics, and metabolomics at defined time points

    • Focus on transitions between growth phases, particularly entry to stationary phase

    • Quantify changes in TrpD expression/activity alongside violacein biosynthetic enzymes

    • Develop computational models that predict flux redistribution based on multi-omics data

  • Advanced Imaging Techniques:

    • Apply Raman microscopy to track violacein accumulation with subcellular resolution

    • Use fluorescent amino acid analogs to visualize protein synthesis dynamics

    • Implement correlative light and electron microscopy to connect metabolic activity with cellular ultrastructure

    • Develop image analysis algorithms to quantify the spatial distribution of tryptophan utilization

  • Quorum Sensing-Synchronized Analysis:

    • Use synthetic biology approaches to control quorum sensing signaling

    • Trigger violacein production in synchronized cell populations

    • Monitor resulting metabolic flux reorganization through multiple analytical techniques

    • Correlate HHL concentration with changes in tryptophan allocation between pathways

These approaches would provide unprecedented insights into the dynamic regulation of tryptophan metabolism in C. violaceum and establish broadly applicable methodologies for studying metabolites with multiple metabolic fates in other biological systems .

What are the most promising future directions for research on C. violaceum TrpD that could advance both fundamental understanding and biotechnological applications?

The most promising future research directions for C. violaceum TrpD span fundamental science and applied biotechnology:

  • Structure-Function Relationship Elucidation:

    • Determine the crystal structure of C. violaceum TrpD in various states (apo, substrate-bound, inhibitor-bound)

    • Map the allosteric networks connecting tryptophan binding to catalytic activity modulation

    • Use this structural knowledge to design rationally engineered variants with desired properties

    • Apply computational approaches like molecular dynamics simulations to understand conformational changes during catalysis and inhibition

  • Synthetic Biology Integration:

    • Develop synthetic regulatory circuits that coordinate TrpD activity with violacein production

    • Create metabolic valves that can dynamically redirect tryptophan flux between protein synthesis and secondary metabolism

    • Design modular systems where TrpD activity can be precisely controlled in response to specific signals

    • Explore the potential for cell-free systems utilizing engineered TrpD variants

  • Evolutionary and Comparative Studies:

    • Compare TrpD from multiple Chromobacterium species with differing violacein production capacities

    • Reconstruct the evolutionary history of TrpD in relation to the acquisition of violacein biosynthesis

    • Apply ancestral sequence reconstruction to test hypotheses about TrpD adaptation

    • Explore natural TrpD diversity as a source of novel variants with desirable properties

  • Advanced Biotechnological Applications:

    • Engineer C. violaceum TrpD for enhanced production of violacein and its derivatives for pharmaceutical applications

    • Develop systems for production of tryptophan-derived compounds beyond violacein

    • Create biosensors based on TrpD for detection of metabolic states or environmental conditions

    • Apply C. violaceum TrpD knowledge to other organisms that synthesize tryptophan-derived secondary metabolites

  • Integrative Systems Biology Approaches:

    • Develop comprehensive metabolic models specifically focused on tryptophan metabolism in C. violaceum

    • Apply flux balance analysis with enzyme constraints to predict optimized genotypes

    • Integrate models with experimental data across multiple scales (molecular to population)

    • Use these models to guide rational engineering for specific biotechnological goals

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.